The reader should note that the ClearView device has not been proven safe and effective for any use at this time. ClearView is currently pursuing clearance by the FDA. The proposed indicated for use statement will read as follows: “A multi-point GSR measurement to provide a general direction for further standard of care evaluation and testing of patients with or without symptoms.”

EPIC Founder and Radiologic Biophysicist Nancy R. Rizzo, PhD, DABR is using her decades of extensive research in electromagnetic medicine and biophotonics to pioneer a revolutionary new device. Learn more

Imagine a world where patients and doctors spend more time focused on prevention and overall wellness and less time on sick care. That world may be closer than you think. Learn More

Shift to a new model of medicine that focuses on prevention, identifying illness root causes, treatment efficacy and disease progression prevention. Learn More